Recent Development of ICH GCG

Similar documents
Evolution and achievements of ICH- GCG (Global Cooperation Group)

ICH Regulators Forum. Dr Peter Arlett EU

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

Trends in the development of regulatory systems by the example of ICH countries

Portland, Oregon, USA (Portland Marriott Downtown Waterfront Hotel)

Yokohama, Japan (Yokohama Royal Park Hotel)

Regional Update ASEAN PPWG

Overview of ICH. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs

Consideration on Global Harmonization

Regional Update ASEAN PPWG

International Medical Device Regulatory Harmonization. Reality or Fantasy?

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

ICH STEERING COMMITTEE October 24-29, 2009 St. Louis, MO, USA SUMMARY

Regional Update ASEAN PPWG

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

Regional Alignment in Asia Pacific -

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

ICH ASSOCIATION 2016 ANNUAL REPORT

SUMMARY REPORT ICH MC TELECONFERENCE April 13, 2017

Quality Risk Management ICH Q9

MEETING REPORT ICH Steering Committee November 2013, Osaka, Japan

Why do we need an addendum to ICH E6?

Minutes ICH Management Committee Meeting Montreal, Canada May 29 - June 1, 2017

Work plan for GCP Inspectors Working Group for 2018

IMDRF Project: List of international standards recognized by IMDRF management committee members

Forward looking approaches & its Experiences of PMDA's ATC

ASSEMBLY AGENDA PAPERS. May 31 & June 1, 2017 Montreal, Canada

Regulatory Conference: KEY TAKE- AWAYS. Engela Dedwith, Eli Lilly

Progress Report in 2016

International trend on medical device regulatory convergence

REGULATORY STRENGTHENING AND CONVERGENCE FOR MEDICINES AND HEALTH WORKFORCE

SUMMARY REPORT ICH MC TELECONFERENCE 26 September 2017

Food Safety Capacity Building: The role of public private partnerships

Feedback on SADC Workshop of Industry & Regulators. Luther Gwaza PhD Consultant

G-20, Multilateralism and Emerging Trade Blocs:

SADC Collaborative Medicines Registration Initiative (Zazibona)

SADC Collaborative Medicines Registration Process (ZAZIBONA) Farai Masekela 13 April 2016

Completing E2B(R3) Compliance in Total Safety 7

Regulatory Cooperation in Europe. Natalie McCoy, CEER Secretary General INOGATE Conference - Brussels, 1 February 2013

APEC Food Safety Cooperation Forum

A Comparative Study of Registration Procedure for Submission of Generic Drug in Brunei Darussalam and Malaysia

ANSI-USAID Standards Alliance Year Four ( ) Plan

Role and Vision of PMDA

Presentation by Julie Sinnamon, CEO Enterprise Ireland. 22 nd November 2016

SME Internationalisation: Characteristics, Barriers and Policy Options

Annex 2 to the HMA esubmission Roadmap: Implementation of mandatory use of ectd format for regulatory submissions

Now We are Getting to the Hard Parts: An Analysis Files Perspective

Discussion paper on. Asia Pacific Quality Register (APQR)

ICH Topic Q4B Annex 6 Uniformity of Dosage Units General Chapter. Step 3

PMDA EPOCH Toward 2020

CALL FOR EXPRESSION OF INTEREST. Seconded National Experts for the ERCEA ERCEA/SNE/143/2017

Addendum to ICH E6 (R2)

FIFTH ASEAN STATE OF THE ENVIRONMENT REPORT

Arab Specialized Food Safety Task Force (ATF)

Japan s Initiatives on Globalization of Higher Education. Prof. Dr. Tsutomu KIMURA

International Partnerships to Improve Oil Spill preparedness, Prevention and Response. Brian Sullivan Executive Director, IPIECA January, 2015

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Rules of Procedure of the Assembly

JICA s Institutional and Human Capacity Building toward SADC s DFI together with SADC-DFRC

Post- Fukushima accident. Action plan. Follow-up of the peer review of the stress tests performed on European nuclear power plants

NRF Funding Opportunities

International Trend on Medical Device Regulatory Convergence

Suggestions for Modification of the Clinical Trials Directive ELN Annual Meeting 01 February 2011

High Level Pharmaceutical Forum

IEG Convenor s Report to CTI

1 The EU Harmonised technical ectd guidance version 4.0

CALL FOR EXPRESSION OF INTEREST. Seconded National Experts for the ERCEA ERCEA/SNE/143/2017

(Non-legislative acts) REGULATIONS

Client Alert. European Commission Proposes Overhaul of EU Clinical Trials Legislation

Health Profession Councils National Strategic Plan

MINIMUM CRITERIA FOR REACH AND CLP INSPECTIONS 1

The place of the Certification procedure in 2017 in the EU regulatory framework and beyond. Prague, 19 September 2017

- Proposal for a Regulation on HTA- DG SANTE - Health Systems and Products Medical Products: safety, quality, innovation

Study definition of CPD

1. Introduction, purpose of this Standard Operating Procedure (SOP)

General FAQ relating to e-submission for Veterinary Applications

- Proposal for a Regulation on HTA- Ioana Siska, MD, PhD DG SANTE - Health Systems and Products Medical Products: safety, quality, innovation

The EUREKA Initiative An Opportunity for Industrial Technology Cooperation between Europe and Japan

TARGETED SUPPORT TO ENHANCE THE IMPLEMENTATION OF THE CARIFORUM-EU EPA

Masterclass NieuweZorg 3.0 De farmaceutische sector op Europees niveau. Author: Elizabeth Kuiper* Date: Maart 2016 * Presentation.

EU GREEN GATEWAY TO JAPAN

SUMMARY REPORT OF THE 17 th ACCSQ MDPWG MEETING

SUMMARY REPORT ICH MC TELECONFERENCE 24 January 2018

Annual report of the Good Clinical Practice Inspectors Working Group 2016

Certification Scheme for a Certificate of Pharmaceutical Product (CPP) IFPMA CPP Network Training Toolkit

Agenda Item 7 CX/ASIA 12/18/9

Transmission to CHMP December Adoption by CHMP for release for consultation December 2008

Facesheet. Date received by Secretariat:

ASEAN Intellectual Property Symposium - ASEAN Regional Economic Integration toward February 2012, Tokyo, Japan

Brussels, 12 June 2014 COUNCIL OF THE EUROPEAN UNION 10855/14. Interinstitutional File: 2012/0266 (COD) 2012/0267 (COD)

Annex X. Co-chairmen's Report ARF-ISG on CBMs Defense Officials' Dialogue

Q11 Development and Manufacture of Drug Substances--Questions and Answers

Regional and sub-regional approaches to the Digital Economy: Lessons from Asia Pacific and Latin America

Therefore the provision of medicines is an area for which a Community regulatory framework should be properly supervised to ensure full and

APEC LSIF Blood Supply Chain Initiative Overview

IFCS CHAMPION. Children and Chemical Safety. Report on Activities. May 2006

Observers Takuya Noro MHLW X X X Hideto Yokoi PMDA Advisor X X X Adriana Gamboa INFARMED X X X

OIE Regional Platform on Animal Welfare for Europe

GLOBAL BIOANALYSIS CONSORTIUM on harmonization of bioanalytical guidance 2014, time for a status update

Transcription:

Recent Development of ICH GCG Japan Pharmaceutical Manufactures Association ICH Project Committee Minoru Kubota, Ph.D. October 12, 2006 APEC 2006, Tokyo JAPAN

ICH Objectives Identification and elimination of the need to duplicate studies to meet different regulatory requirements More efficient use of resources in the R&D process Quicker access for patients to safe and effective new medicines

ICH Activity by the regulators and industry EU EC EFPIA ICH Secretariat IFPMA US FDA PhRMA ICH Japan MHLW JPMA Observers WHO Health Canada EFTA

ICH Member Countries Health Canada USA ICH Secretariat EU WHO & EFTA Japan

International Conference on Harmonisation ICH 1 : 1991 Brussels, Belgium ICH 2 : 1993 Orlando, U.S.A ICH 3 : 1995 Yokohama, Japan ICH 4 : 1997 Brussels, Belgium ICH 5 : 2000 San Diego, U.S.A ICH 6 : 2003 Osaka, Japan ICH 7 : 200? EU

Where is ICH now? A mature harmonisation initiative Over fifty technical guidelines Increased interest in and use of ICH guidelines globally Formation and evolution of Global Cooperation Group (GCG)

ICH and non-ich regions ICH outcomes have influenced regulatory activities in non-ich countries Some ICH Guide Lines (GLs) are not adopted to non-ich countries Adoption by non-ich countries may lead to local disharmony if variations or amendments are not made

Global Cooperation Group (GCG) Formed in 1999 as a sub-committee reporting directly to Sterring Commiittee (SC) Objective: establish relationship with non-ich regions/countries to inform and to develop interactions Membership: one representative of each six parties and observers (Health Canada, WHO)

Mission of ICH-GCG To promote a mutual understanding of regional harmonisation initiatives in order to facilitate the harmonisation process related to ICH guidelines regionally and globally To facilitate the capacity of drug regulatory authorities and industry to utilise them

ICH Principles of ICH-GCG Not seek to impose ICH views on any country/company Work as closely as possible with WHO and other international organizations to achieve these goals GCG (ICH sub-committee) Provide information upon request from non-ich countries, also information available ICH Web site

Regional Harmonisation Initiatives (RHI) APEC Asia-Pacific Economic Cooperation ASEAN (ACCSQ PPWG) Association of South-East Asian Nations GCC Gulf Cooperation Council PANDRH (PAHO) Pan American Network for Drug Regulatory Harmonisation SADC Southern African Development Community

RHI countries APEC APEC GCC PANDRH ASEAN SADC APEC

Common Understanding GCG meeting Attend, make presentations, raise questions SC meeting Attend technical discussions (do not raise questions) Attend GCG reports to SC, comment (usually asked by SC chair) EWG (Expert Working Group) meeting Present to learn about harmonisation activities ** participated in Q10, Yokohama 2006

GCG Opportunities GCG is open to permanent representatives of non-ich regions with harmonisation initiatives GCG identifies with RHIs the topics and process issues for discussion, collaboration and potential development All proposed GCG actions have to be endorsed by ICH SC Discuss specific issues with ICH regulators and industry representatives Building confidence and trust

GCG recent developments Training strategy document endorsed by SC Ongoing Survey on structure organisation of local RHIs and Good Harmonisation Practices

Strategy on Training and Capacity Building Related to the Use of ICH Guidelines Issue & Background Principles and Recommendations of the GCG in responding to Training Requests Delivery of training and capacity-building within a regional strategy Reference : http://www.ich.org/ Global Cooperation Group => Reports

Progress on Outputs from Objectives : RHI Survey - 1 Collect and publish (baseline) information on RHIs and on identifying GHPs Yokohama 06 <GCG considered> : Proposal for a public paper on comparative study of RHIs and keys to successful harmonisation outcomes

Progress on Outputs from RHI Survey - 2 Agreement in principle to proceed in stepwise fashion : Collect necessary information from RHIs and complete sample comparative table and profile narrative using PANDRH as model Goals : Promote understanding of RHIs, GCG and best practices in harmonisation

Summary - 1 GCG discussed options for reflecting on progress made to date; periodic review also mandated by SC Proposal for Chicago 06 meeting to update GCG Procedures according to the progress made Transparency, communication and engagement through GCG seen as increasingly important

Summary - 2 Necessary enhanced interaction between ICH and non-ich regions win activity ICH continues to balance development of important new topics with maintenance and implementation activities

APEC